Supplemental Balance Sheet and Cash Flow Information - Changes in Carrying Amount of Goodwill (Details) - USD ($) $ in Thousands |
12 Months Ended | |
---|---|---|
Jun. 30, 2024 |
Jun. 30, 2023 |
|
Beginning balance | $ 872,737 | $ 822,101 |
Acquisitions | 104,650 | |
Held-for-sale goodwill | (1,400) | |
Adjustments | 51,257 | |
Currency translation | (3,324) | (621) |
Ending balance | 972,663 | 872,737 |
Protein Sciences | ||
Beginning balance | 427,027 | 376,493 |
Held-for-sale goodwill | (1,400) | |
Adjustments | 51,257 | |
Currency translation | (2,178) | (723) |
Ending balance | 423,449 | 427,027 |
Diagnostics and Genomics | ||
Beginning balance | 445,710 | 445,608 |
Acquisitions | 104,650 | |
Currency translation | (1,146) | 102 |
Ending balance | $ 549,214 | $ 445,710 |
X | ||||||||||
- Definition The amount of adjustment for goodwill held-for-sale. No definition available.
|
X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Amount of foreign currency translation gain (loss) which increases (decreases) asset representing future economic benefit from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of increase (decrease) from measurement period adjustment of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|